Position in INSM
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$540,670
-$6,798,598 QoQ
Shares Held
5,071
-88.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#393
of 663 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NWAM LLC holds $8,220,053 across 8 Biotechnology names. INSM ranks #3 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,129 | $5,031,378 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,680 | $1,047,547 | |
| 3 | INSM |
INSMED Inc
This page
|
5,071 | $540,670 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
5,530 | $432,833 | |
| 5 | NTLA |
Intellia Therapeutics, Inc.
|
19,540 | $330,616 | |
| 6 | EXEL |
Exelixis, Inc.
|
5,619 | $305,729 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
912 | $274,539 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
3,238 | $256,741 |
All Filings in INSM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $540,670 | 5,071 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $7,339,268 | 44,883 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $6,784,427 | 38,982 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $7,133,967 | 49,538 | Shares | Sole | 2026-02-04 | |
| 2025-06-30 | $5,017,910 | 49,860 | Shares | Sole | 2026-02-04 | |
| 2025-03-31 | $4,103,562 | 53,789 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,492,067 | 36,096 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||